27 results on '"Schmidt, Grethe"'
Search Results
2. RNA analysis of tape strips to rule out melanoma in lesions clinically assessed as cutaneous malignant melanoma: A diagnostic study
- Author
-
Heerfordt, Ida M., Philipsen, Peter A., Andersen, Jeppe D., Langhans, Linnea, Schmidt, Grethe, Morling, Niels, and Wulf, Hans Christian
- Published
- 2023
- Full Text
- View/download PDF
3. Distinct clinical parameters were associated with shorter spontaneous resolution in children with non‐tuberculous mycobacterial lymphadenitis.
- Author
-
Jensen, Frederikke Nonboe, Nielsen, Allan Bybeck, Dungu, Kia Hee Schultz, Poulsen, Anja, Schmidt, Grethe, Hjuler, Thomas, Zhang, He, Vissing, Nadja Hawwa, and Nygaard, Ulrikka
- Subjects
SKIN discoloration ,LYMPH nodes ,UNIVERSITY hospitals ,MYCOBACTERIA ,ABSCESSES ,LYMPHADENITIS - Abstract
Aim: Non‐tuberculous mycobacteria (NTM) lymphadenitis typically resolves spontaneously, yet factors influencing the duration remain explored. We aimed to identify clinical parameters associated with shorter spontaneous resolution. Methods: This cohort study included children with NTM lymphadenitis from 1 January 2015 to 1 March 2021 at Copenhagen University Hospital. Time‐to‐event analysis assessed clinical parameters associated with the duration of NTM lymphadenitis. Results: Sixty children (57% boys) with a median age of 24 months (range 11–84) were included; 13 (22%) received primary surgery, 13 (22%) underwent surgery after a wait‐and‐see period and 34 (57%) received no intervention. In children without intervention, the median duration was 10 months (range 2–25). Faster resolution was associated with parental‐reported lymph node enlargement within 2 weeks (HR 2.3, 95% CI 1.0–5.0; p = 0.044), abscess on ultrasound examination (HR 3.3, 95% CI 1.5–7.3; p = 0.003) and skin discoloration and/or perforation within 3 months of onset (HR 4.3, 95% CI 1.3–14.4; p = 0.017 and HR 3.7, 95% CI 1.5–9.1; p = 0.005). Conclusion: Knowledge of predictors for shorter spontaneous resolution of NTM lymphadenitis, such as rapid initial lymph node enlargement, abscess on ultrasound examination, and skin discoloration and/or perforation within 3 months of disease onset, may guide clinical management decisions concerning surgery versus a conservative approach. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Surgical planning with line‐field confocal optical coherence tomography for recurrent infiltrative basal cell carcinoma: visualizing subclinical tumor for margin adjustment.
- Author
-
Jacobsen, Kevin, Wenande, Emily, Ortner, Vinzent Kevin, Schmidt, Grethe, and Haedersdal, Merete
- Published
- 2024
- Full Text
- View/download PDF
5. Heterotopic epithelialization presenting as a non-healing scalp wound after surgery
- Author
-
Askaner, Gustav, Rasmussen, Rune, Schmidt, Grethe, and Lund, Eva Løbner
- Published
- 2017
- Full Text
- View/download PDF
6. Radionuclide leakage monitoring during hyperthermic isolated limb perfusion for treatment of local melanoma metastasis in an extremity
- Author
-
Paulsen, Ida F., Chakera, Annette Hougaard, Schmidt, Grethe, Dreje, Jennifer, Klyver, Helle, Oturai, Peter S., Hesse, Birger, Drzewiecki, Krystztof, and Mortensen, Jann
- Published
- 2015
- Full Text
- View/download PDF
7. Detection of cutaneous malignant melanoma using RNA sampled by tape strips: A study protocol.
- Author
-
Heerfordt, Ida M., Andersen, Jeppe D., Philipsen, Peter A., Langhans, Linnea, Tvedebrink, Torben, Schmidt, Grethe, Poulsen, Thomas, Lerche, Catharina M., Morling, Niels, and Wulf, Hans Christian
- Subjects
MELANOMA ,RESEARCH protocols ,RNA ,ADHESIVE tape ,POLYMERASE chain reaction ,RNA analysis ,ATHLETIC tape - Abstract
Background: Cutaneous malignant melanoma (CMM) is curable if detected in its early stages. However, the clinical recognition of CMM is challenging. An American research group has shown promising results in detecting CMM based on RNA profiles sampled from suspicious lesions with tape strips. We aim to further develop this technique and validate if RNA profiles sampled with tape strips can detect CMM. Methods: This prospective cohort study will include approximately 200 lesions clinically suspected of CMM requiring surgical removal. Tape stripping of the lesions will be performed just before surgical excision. Subsequently, RNA on the tape strips is analyzed using quantitative real-time polymerase chain reaction with TaqMan technology. The results are combined into a binary outcome where positive indicates CMM and negative indicates no CMM. The histopathological diagnosis of the lesions will be used as the gold standard. The main outcome is the results of the RNA test and the histopathological diagnosis, which, combined, provide the sensitivity and specificity of the test. Discussion: The accuracy of the clinical examination in CMM diagnostics is limited. This clinical trial will explore the ability to use RNA analysis to improve the management of suspicious lesions by enhancing early diagnostic accuracy. Hopefully, it can reduce the number of benign lesions being surgically removed to rule out CMM and decrease patient morbidity. Trial registration: The project was approved by The Committee on Health Research Ethics of the Capital Region of Denmark (H-15010559) and registered at the Danish Data Protection Agency (BFH-2015-065). [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Risk factors for local atypical fibroxanthoma recurrence and progression to pleomorphic dermal sarcoma: A meta‐analysis of individualized participant data.
- Author
-
Ørholt, Mathias, Aaberg, Frederik L., Abebe, Kiya, Walsh, S., Roenigk, Randall K., Venzo, Alessandro, Schmidt, Grethe, Klyver, Helle, Jensen, David H., Herly, Mikkel, and Vester‐Glowinski, Peter V.
- Published
- 2022
- Full Text
- View/download PDF
9. Dermal echogenicity: a biological indicator of individual cumulative UVR exposure?
- Author
-
Sandby-Møller, Jane, Thieden, Elisabeth, Philipsen, Peter Alshede, Schmidt, Grethe, and Wulf, Hans Christian
- Published
- 2004
- Full Text
- View/download PDF
10. A Multidisciplinary Approach to Complex Dermal Sarcomas Ensures an Optimal Clinical Outcome.
- Author
-
Trøstrup, Hannah, Bigdeli, Amir K., Krogerus, Christina, Kneser, Ulrich, Schmidt, Grethe, and Schmidt, Volker J.
- Subjects
AESTHETICS ,PLASTIC surgery ,SKIN tumors ,TREATMENT delay (Medicine) ,DISEASE relapse ,FUNCTIONAL assessment ,DERMIS ,HEALTH care teams ,INTERPROFESSIONAL relations ,SARCOMA ,RARE diseases - Abstract
Simple Summary: Knowledge of cutaneous or dermal sarcomas is crucial due to the initially peaceful appearance of skin tumours, causing delays in accurate diagnoses. They can easily be mistaken for benign skin appendages or moles. This clinical entity spans from low-grade tumours with practically no metastatic potential to highly aggressive neoplasms with substantial morbidity. Initial adequate resection is the absolute mainstay of successful therapy. Extensive tissue defects after resection necessitate a multidisciplinary approach involving reconstructive surgical planning from onset. Clinical and morphological types of dermal sarcomas are presented together with examples of cases undergoing interdisciplinary treatment and advanced microsurgical reconstructive therapy. Clinicians should be aware of the types of dermal sarcomas; their specific clinical presentations and growth patterns; as well as the necessity of clear surgical margins and the significant progress in reconstructive surgery, which gives new hope for future management of complex dermal sarcomas. Primary dermal sarcomas (PDS) belong to a highly clinically, genetically and pathologically heterogeneous group of rare malignant mesenchymal tumours primarily involving the dermis or the subcutaneous tissue. The tumours are classified according to the mesenchymal tissue from which they originate: dermal connective tissue, smooth muscle or vessels. Clinically, PDS may mimic benign soft tissue lesions such as dermatofibromas, hypertrophic scarring, etc. This may cause substantial diagnostic delay. As a group, PDS most commonly comprises the following clinicopathological forms of dermal sarcomas: dermatofibrosarcoma protuberans (DFSP), atypical fibroxanthoma (AFX), dermal undifferentiated pleomorphic sarcoma (DUPS), leiomyosarcoma (LMS), and vascular sarcomas (Kaposi's sarcoma, primary angiosarcoma, and radiation-induced angiosarcoma). This clinical entity has a broad spectrum regarding malignant potential; however, local aggressive behaviour in some forms causes surgical challenges. Preoperative, individualised surgical planning with complete free margins is pivotal along with a multidisciplinary approach and collaboration across highly specialised surgical and medical specialties. The present review gives a structured overview of the most common forms of dermal sarcomas including surgical recommendations and examples for advanced reconstructions as well as the current adjunctive medical treatment strategies. Optimal aesthetic and functional outcomes with low recurrence rates can be achieved by using a multidisciplinary approach to complex dermal sarcomas. In cases of extended local tumour invasion in dermal sarcomas, advanced reconstructive techniques can be applied, and the interdisciplinary microsurgeon should be an integral part of the sarcoma board. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Psychoeducational Intervention for Patients With Cutaneous Malignant Melanoma: A Replication Study
- Author
-
Boesen, Ellen H., Ross, Lone, Frederiksen, Kirsten, Thomsen, Birthe L., Dahlstrøm, Karin, Schmidt, Grethe, Næsted, Jesper, Krag, Christen, and Johansen, Christoffer
- Published
- 2005
- Full Text
- View/download PDF
12. Ocular lens blue autofluorescence cannot be used as a measure of individual cumulative UVR exposure
- Author
-
Sandby-Møller, Jane, Thieden, Elisabeth, philipsen, Peter Alshede, Schmidt, Grethe, and wulf, Hans Christian
- Published
- 2004
13. Surgical management of rhinocerebral mucormycosis: A case series
- Author
-
Wolthers, Mette Stueland, Schmidt, Grethe, Gjørup, Caroline Asirvatham, Helweg-Larsen, Jannik, Rubek, Niclas, and Jensen, Lisa Toft
- Published
- 2021
- Full Text
- View/download PDF
14. The Danish Melanoma Database
- Author
-
Rosenkrantz Hölmich,Lisbet, Klausen,Siri, Spaun,Eva, Schmidt,Grethe, Gad,Dorte, Svane,Inge Marie, Smith,Henrik, Lorentzen,Henrik, and Helene Ibfelt,Else
- Subjects
Clinical Epidemiology - Abstract
Lisbet Rosenkrantz Hölmich,1 Siri Klausen,2 Eva Spaun,3 Grethe Schmidt,4 Dorte Gad,5 Inge Marie Svane,6,7 Henrik Schmidt,8 Henrik Frank Lorentzen,9 Else Helene Ibfelt10 1Department of Plastic Surgery, 2Department of Pathology, Herlev-Gentofte Hospital, University of Copenhagen, Herlev, 3Institute of Pathology, Aarhus University Hospital, Aarhus, 4Department of Plastic and Reconstructive Surgery, Breast Surgery and Burns, Rigshospitalet – Glostrup, University of Copenhagen, Copenhagen, 5Department of Plastic Surgery, Odense University Hospital, Odense, 6Center for Cancer Immune Therapy, Department of Hematology, 7Department of Oncology, Herlev-Gentofte Hospital, University of Copenhagen, Herlev, 8Department of Oncology, 9Department of Dermatology, Aarhus University Hospital, Aarhus, 10Registry Support Centre (East) – Epidemiology and Biostatistics, Research Centre for Prevention and Health, Glostrup– Rigshospitalet, University of Copenhagen, Glostrup, Denmark Aim of database: The aim of the database is to monitor and improve the treatment and survival of melanoma patients.Study population: All Danish patients with cutaneous melanoma and in situ melanomas must be registered in the Danish Melanoma Database (DMD). In 2014, 2,525 patients with invasive melanoma and 780 with in situ tumors were registered. The coverage is currently 93% compared with the Danish Pathology Register.Main variables: The main variables include demographic, clinical, and pathological characteristics, including Breslow’s tumor thickness, ± ulceration, mitoses, and tumor–node–metastasis stage. Information about the date of diagnosis, treatment, type of surgery, including safety margins, results of lymphoscintigraphy in patients for whom this was indicated (tumors > T1a), results of sentinel node biopsy, pathological evaluation hereof, and follow-up information, including recurrence, nature, and treatment hereof is registered. In case of death, the cause and date are included. Currently, all data are entered manually; however, data catchment from the existing registries is planned to be included shortly.Descriptive data: The DMD is an old research database, but new as a clinical quality register. The coverage is high, and the performance in the five Danish regions is quite similar due to strong adherence to guidelines provided by the Danish Melanoma Group. The list of monitored indicators is constantly expanding, and annual quality reports are issued. Several important scientific studies are based on DMD data.Conclusion: DMD holds unique detailed information about tumor characteristics, the surgical treatment, and follow-up of Danish melanoma patients. Registration and monitoring is currently expanding to encompass even more clinical parameters to benefit both patient treatment and research. Keywords: melanoma, malignant melanoma, clinical database, quality database, melanoma registry, Denmark
- Published
- 2016
15. Reconstructive considerations following a necrotic spider bite on the face: A case report
- Author
-
Mikkelsen, Joachim, Schmidt, Grethe, and Holmgaard, Rikke
- Published
- 2017
- Full Text
- View/download PDF
16. Gigantic subcutaneous lipoma – A case report
- Author
-
Lang, Christian Lyngsaa, Andersen, Christine Schmidt, Schmidt, Grethe, and Bonde, Christian
- Published
- 2015
- Full Text
- View/download PDF
17. Radiation exposure to surgical staff during hyperthermic isolated limb perfusion with 99mTechnetium labeled red blood cells.
- Author
-
Kristoffersen, Ulrik Sloth, Straalman, Kristina, Schmidt, Grethe, Klyver, Helle, Mortensen, Jann, Andersen, Peter Andreas, Chakera, Annette Hougaard, and Kjaer, Andreas
- Subjects
RADIATION exposure ,SURGEONS ,EXTREMITIES (Anatomy) -- Surgery ,AMPUTATION complications ,TECHNETIUM ,ERYTHROCYTES ,THERMOTHERAPY - Abstract
Purpose: Hyperthermic isolated limb perfusion (HILP) is an effective method in the treatment of recurrent melanomas and soft tissue sarcomas. To avoid systemic toxicity, leakage from the limb perfusate into the systemic circulation is real-time monitored by administration of a radioactive agent to the limb circuit. This has made HILP safe for the patient. However, the radiation exposure to the surgical staff has never been measured and could be a limiting factor for the use of HILP. The purpose of the present study was to measure and evaluate the radiation exposure to the surgical staff performing HILP with 99mTechnetium labeled red blood cells. Materials and methods: Thirteen patients had HILP performed in 11 lower limbs and two upper limbs at our inpatient clinic between October 2006 and February 2007. The surgeon and nurse had thermoluminescence dosimetry (TLD) chips attached to the finger pulp and to the ring area of the left fourth finger, as well as an electronic dosimeter attached to the anterior lining of the trousers. The anesthesiologist and perfusion technologist also carried electronic dosimeters. Results: The surgeon had the highest radioactive exposure with an average dose per procedure to the finger pulp of 16.2 µSv, to the ring area of 8.5 µSv, and to the abdominal wall of 4.2 ± 0.6 µSv. Conclusions: HILP with 99mtechnetium-labeled red blood cells does not constitute a safety risk to the operating team with respect to radioactive exposure. Routine dose monitoring of the staff or special precautions for fertile women are not necessary. [ABSTRACT FROM AUTHOR]
- Published
- 2009
- Full Text
- View/download PDF
18. Preoperative Embolization of a Solitary Fibrous Tumor Originating from External Auditory Meatus: A Case Report with Literature Review.
- Author
-
Ciochon, Urszula Maria, Schmidt, Grethe, Jensen, Ruben Juhl, Loya, Anand C., Lönn, Lars Birger, and Shekhrajka, Nitesh
- Subjects
- *
EAR canal , *LITERATURE reviews , *THERAPEUTIC embolization , *GENE fusion , *SURGICAL site - Abstract
Solitary fibrous tumors (SFTs) are mesenchymal, fibroblastic tumors with mostly favorable, but still unpredictable prognosis. Their rarity and occurrence at a variety of locations coupled with variable histological appearance make the diagnosis a challenge. This can be resolved by histological and immunohistochemical analysis on the histologic material eventually coupled with demonstration of NAB2-STAT6 gene fusion by next generation sequencing (NGS) analysis. Tumor removal with clear surgical margins is sufficient for complete cure in most cases. Percutaneous transcatheter embolization in well-vascularized lesions may minimize the risk of bleeding during subsequent removal. In this article we present a rare case of SFT arising from the external auditory canal and treated with preoperative endovascular arterial embolization. A literature review with focus on diagnostics and treatment of this entity in the head and neck region is following. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Iatrogenic cerebral radiation necrosis.
- Author
-
Hilton CMH, Specht L, Loebner Lund E, Martens PC, Schmidt G, and Krarup LH
- Subjects
- Animals, Bevacizumab adverse effects, Humans, Iatrogenic Disease, Mice, Necrosis etiology, Radiation Injuries complications, Vascular Endothelial Growth Factor A
- Abstract
Cerebral radiation necrosis is the most serious late reaction to high doses of ionising radiation to the brain, and its treatment is generally unsatisfactory. We present a patient who developed cerebral radiation necrosis after protracted fluoroscopy during repeated embolisations of an extracranial arteriovenous malformation. Treatment with bevacizumab (a humanised murine monoclonal antibody against vascular endothelial growth factor) was followed by neurological and radiological improvements., Competing Interests: Competing interests: LS is on advisory board for Takeda, MSD and Kyowa Kirin; received honoraria from Merck Darmstadt, MSD, Takeda and Kyowa Kirin; and has research agreements with Varian and ViewRay., (© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2021
- Full Text
- View/download PDF
20. The value of FDG PET/CT for follow-up of patients with melanoma: a retrospective analysis.
- Author
-
Vensby PH, Schmidt G, Kjær A, and Fischer BM
- Abstract
The incidence of melanoma (MM) is among the fastest rising cancers in the western countries. Positron Emission Tomography with Computed Tomography (PET/CT) is a valuable non-invasive tool for the diagnosis and staging of patients with MM. However, research on the value of PET/CT in follow-up of melanoma patients is limited. This study assesses the diagnostic value of PET/CT for follow-up after melanoma surgery. This retrospective study includes patients with MM who performed at least one PET/CT scan after initial surgery and staging. PET/CT findings were compared to histology, MRI or fine needle aspiration (FNA) to estimate the diagnostic accuracy. The diagnostic performance of PET/CT performed in patients with and without a clinical suspicion of relapse was compared. 238 patients (526 scans) were included. Of the 526 scans 130 (25%) scans were PET-positive, 365 (69%) PET-negative, and 28 (5%) had equivocal findings. Sensitivity was 89% [0.82-0.94], specificity 92% [0.89-0.95], positive and negative predictive values of 78% [0.70-0.84] and 97% [0.94-0.98] respectively. When stratified for reason of referral there was no statistical significant difference in the diagnostic accuracy of PET/CT between patients referred with or without a clinical suspicion of relapse. This study demonstrates that PET/CT despite a moderate sensitivity has a high negative predictive value in the follow-up of melanoma patients. Thus, a negative PET/CT-scan essentially rules out relapse. However, the frequency of false positive findings is relatively high, especially among patients undergoing a "routine" PET/CT with no clinical suspicion of relapse, potentially causing anxiety and leading to further diagnostic procedures., Competing Interests: None.
- Published
- 2017
21. The Danish Melanoma Database.
- Author
-
Hölmich LR, Klausen S, Spaun E, Schmidt G, Gad D, Svane IM, Schmidt H, Lorentzen HF, and Ibfelt EH
- Abstract
Aim of Database: The aim of the database is to monitor and improve the treatment and survival of melanoma patients., Study Population: All Danish patients with cutaneous melanoma and in situ melanomas must be registered in the Danish Melanoma Database (DMD). In 2014, 2,525 patients with invasive melanoma and 780 with in situ tumors were registered. The coverage is currently 93% compared with the Danish Pathology Register., Main Variables: The main variables include demographic, clinical, and pathological characteristics, including Breslow's tumor thickness, ± ulceration, mitoses, and tumor-node-metastasis stage. Information about the date of diagnosis, treatment, type of surgery, including safety margins, results of lymphoscintigraphy in patients for whom this was indicated (tumors > T1a), results of sentinel node biopsy, pathological evaluation hereof, and follow-up information, including recurrence, nature, and treatment hereof is registered. In case of death, the cause and date are included. Currently, all data are entered manually; however, data catchment from the existing registries is planned to be included shortly., Descriptive Data: The DMD is an old research database, but new as a clinical quality register. The coverage is high, and the performance in the five Danish regions is quite similar due to strong adherence to guidelines provided by the Danish Melanoma Group. The list of monitored indicators is constantly expanding, and annual quality reports are issued. Several important scientific studies are based on DMD data., Conclusion: DMD holds unique detailed information about tumor characteristics, the surgical treatment, and follow-up of Danish melanoma patients. Registration and monitoring is currently expanding to encompass even more clinical parameters to benefit both patient treatment and research., Competing Interests: The DMD cooperates with the medical industry in development and research. This includes testing of oncologic products, clinical tests, participation in advisory boards, meetings, and teaching. There are no financial disclosures in relation to this work. The authors report no other conflicts of interest in this work.
- Published
- 2016
- Full Text
- View/download PDF
22. Giant congenital melanocytic nevus: report from 30 years of experience in a single department.
- Author
-
Rasmussen BS, Henriksen TF, Kølle SF, and Schmidt G
- Subjects
- Adolescent, Adult, Child, Child, Preschool, Curettage, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Middle Aged, Retrospective Studies, Skin Transplantation, Surgical Flaps, Tissue Expansion, Treatment Outcome, Young Adult, Dermatologic Surgical Procedures methods, Nevus, Pigmented surgery, Skin Neoplasms surgery
- Abstract
Giant congenital melanocytic nevi (GCMN) occur in 1:20,000 livebirths and are associated with increased risk of malignant transformation. The treatment of GCMN from 1981 to 2010 in a tertiary referral center was reviewed evaluating the modalities used, cosmetic results, associated complications, and malignant transformation. Of 35 patients, 25 underwent surgery. Curettage was most frequently used (64%) followed by excision and tissue expansion (20%). Six percent of the patients treated with curettage, and 78% of the patients who received excision surgery required more than 1 planned procedure, and 25% versus 44% required unplanned additional surgery, respectively. Complications were noted in 25% and 67% of the patients, respectively. Cosmetic result was satisfying in 76% of patients without difference between the groups. No malignant transformation was found during a mean follow-up of 11 years. Curettage is a gentle alternative to excision with a lower complication rate and good cosmetic outcome.
- Published
- 2015
- Full Text
- View/download PDF
23. Recurrence and survival after neck dissections in cutaneous head and neck melanoma.
- Author
-
Andersen PS, Chakera AH, Thamsborg AK, Kølle SF, Schmidt G, Klyver H, and Drzewiecki KT
- Subjects
- Adolescent, Adult, Aged, Aged, 80 and over, Child, Female, Humans, Lymphatic Metastasis, Male, Melanoma secondary, Middle Aged, Neck Dissection methods, Neoplasm Recurrence, Local mortality, Prognosis, Retrospective Studies, Survival Rate, Young Adult, Head and Neck Neoplasms mortality, Head and Neck Neoplasms surgery, Melanoma mortality, Melanoma surgery, Neck Dissection mortality
- Abstract
Introduction: An important prognostic factor in head and neck melanoma is the status of the regional lymph nodes since the presence of metastatic disease in the nodes greatly aggravates the prognosis. There is no consensus on the surgical treatment algorithm for this group. Our aim was to study if there is a difference in nodal recurrence and survival after radical, modified or selective neck dissection., Methods: A total of 57 patients treated for regional meta-stases of head and neck melanoma were analysed retrospectively with respect to type of neck dissection, use of sentinel node biopsy, nodal recurrence and survival., Results: After a median 127-month (range: 22-290) follow-up period, we showed that there was no significant difference in nodal recurrence between three different dissection groups (11% for radical node dissection, 24% for modified radical node dissection and 23% for selective node dissection, p > 0.05). No significant difference in five-year survival was observed between the dissection types (56% for radical node dissection, 61% for modified radical node dissection and 48% for selective node dissection, p = 0.613). Multivariate and univariate analysis revealed that patients with metastatic deposits in sentinel nodes had a better survival than patients with clinically palpable nodes (five-year survival rate: 70% versus 36%, p = 0.008)., Conclusion: The extent of neck dissection does not significantly influence the rate of recurrence or survival. This study indicates that there is a survival benefit for patients who undergo completion lymph node dissection following a positive sentinel node biopsy., Funding: not relevant., Trial Registration: not relevant.
- Published
- 2014
24. Tumour response after hyperthermic isolated limb perfusion for locally advanced melanoma.
- Author
-
Paulsen IF, Chakera AH, Drejøe JB, Klyver H, Dahlstrøm K, Oturai PS, Mortensen J, Hesse B, Schmidt G, and Drzewiecki K
- Subjects
- Adult, Aged, Aged, 80 and over, Antineoplastic Agents administration & dosage, Combined Modality Therapy, Disease Progression, Extremities, Female, Follow-Up Studies, Humans, Lymphatic Metastasis, Male, Melanoma mortality, Melanoma pathology, Melphalan administration & dosage, Middle Aged, Prospective Studies, Skin Neoplasms mortality, Skin Neoplasms pathology, Survival Rate, Treatment Outcome, Tumor Necrosis Factor-alpha administration & dosage, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Chemotherapy, Cancer, Regional Perfusion methods, Hyperthermia, Induced, Melanoma secondary, Melanoma therapy, Skin Neoplasms secondary, Skin Neoplasms therapy
- Abstract
Introduction: The aim was to describe tumour response, complications, recurrence and survival after hyperthermic isolated limb perfusion (ILP) with melphalan or melphalan in combination with tumour necrosis factor-alpha in patients with melanoma metastases confined to an extremity., Material and Methods: A total of 84 perfusions were performed (53 women, 31 men, median age 63 years) from 1993 to 2010. 95% of the perfusions were administered to the lower limbs and 5% to the upper limbs. The inclusion criteria were recurrent and/or clinically apparent cutaneous/subcutaneous extremity in-transit melanoma metastases., Results: The response rate after ILP was 85%; 42% had complete response (CR), 43% partial response (PR), 12% no change (NC) and 3% progression. Two- and five-year survival rates were 57% and 31%, respectively, and they were higher for patients with than without lymph node metastases. Time from ILP to recurrence was a median of seven months (range 1-37 months) for patients with CR or PR. Survival was longer for patients with CR or PR than for patients showing NC or progression. Several patients had mild or moderate local toxicity reactions, two patients developed severe local toxicity., Conclusion: ILP induces tumour regression in the vast majority of patients. One patient, i.e. 1% of the group, died from surgical complications. Otherwise, ILP treatment had an acceptable morbidity in this group of very sick patients. We are convinced that the treatment should be offered to improve local disease control in patients with multiple and/or recurrent melanoma confined to an extremity if surgical excision is not possible., Funding: not relevant., Trial Registration: not relevant.
- Published
- 2014
25. Primary localised cutaneous amyloidosis--a systematic review.
- Author
-
Kaltoft B, Schmidt G, Lauritzen AF, and Gimsing P
- Subjects
- Amyloidosis, Familial blood, Humans, Immunoglobulin Light Chains blood, Recurrence, Risk Assessment, Skin Diseases, Genetic blood, Amyloidosis, Familial pathology, Disease Progression, Skin Diseases, Genetic pathology
- Abstract
Introduction: Amyloidosis is defined as extracellular deposits of heterogenic, misfolded proteins, amyloid fibrils, in various tissues. The aim of our study was to review the literature and to evaluate the risk of developing systemic amyloidosis (SA) and the risk of local recurrence of primary localised cutaneous amyloidosis (PLCA). The method of treatment was compared to the risk of local recurrence., Methods: A literature search produced 77 articles with localised cutaneous amyloidosis, 23 articles were excluded; thus, a total of 54 articles were included., Results: A total of 94 patients were included with a male:female ratio of 1.2:1.0. The median age was 57 years (range 24-87 years). The most common tumour localisation was in the head and neck region with a total of 38 lesions (34%), and 20 patients (22%) had two or more lesions in different locations. The nodular subtype was reported in 65 patients (69%). Only 29 patients received therapy with eight patients having two or more treatments (28%). Eight patients (9%) had local recurrence and all were nodular PLCA, which were mainly seen in males and localised in the face. One patient developed SA (1%); in fact, this was the only patient who was positive for monoclonal amyloid light chain amyloidosis by immunoelectrophoresis of the serum., Conclusion: Our review suggests that PLCA is a benign disease that has a good prognosis and that it is associated with a low risk of developing SA (1%). The risk of developing local recurrence or developing new lesions was 9%, and no significant differences were found when compared to the primary treatment.
- Published
- 2013
26. Radiation exposure to surgical staff during hyperthermic isolated limb perfusion with 99m Technetium labeled red blood cells.
- Author
-
Kristoffersen US, Straalman K, Schmidt G, Klyver H, Mortensen J, Andersen PA, Chakera AH, and Kjaer A
- Subjects
- Female, Humans, Radiometry, Chemotherapy, Cancer, Regional Perfusion methods, Erythrocytes metabolism, Health Personnel, Neoplasms therapy, Occupational Exposure, Radiopharmaceuticals adverse effects, Technetium adverse effects
- Abstract
Purpose: Hyperthermic isolated limb perfusion (HILP) is an effective method in the treatment of recurrent melanomas and soft tissue sarcomas. To avoid systemic toxicity, leakage from the limb perfusate into the systemic circulation is real-time monitored by administration of a radioactive agent to the limb circuit. This has made HILP safe for the patient. However, the radiation exposure to the surgical staff has never been measured and could be a limiting factor for the use of HILP. The purpose of the present study was to measure and evaluate the radiation exposure to the surgical staff performing HILP with (99m)Technetium labeled red blood cells., Materials and Methods: Thirteen patients had HILP performed in 11 lower limbs and two upper limbs at our inpatient clinic between October 2006 and February 2007. The surgeon and nurse had thermoluminescence dosimetry (TLD) chips attached to the finger pulp and to the ring area of the left fourth finger, as well as an electronic dosimeter attached to the anterior lining of the trousers. The anesthesiologist and perfusion technologist also carried electronic dosimeters., Results: The surgeon had the highest radioactive exposure with an average dose per procedure to the finger pulp of 16.2 microSv, to the ring area of 8.5 microSv, and to the abdominal wall of 4.2 +/- 0.6 microSv., Conclusions: HILP with (99m)technetium-labeled red blood cells does not constitute a safety risk to the operating team with respect to radioactive exposure. Routine dose monitoring of the staff or special precautions for fertile women are not necessary.
- Published
- 2009
- Full Text
- View/download PDF
27. Survival after a psychoeducational intervention for patients with cutaneous malignant melanoma: a replication study.
- Author
-
Boesen EH, Boesen SH, Frederiksen K, Ross L, Dahlstrøm K, Schmidt G, Naested J, Krag C, and Johansen C
- Subjects
- Adult, Female, Humans, Male, Melanoma psychology, Middle Aged, Skin Neoplasms psychology, Survival Analysis, Melanoma therapy, Patient Education as Topic, Psychotherapy, Skin Neoplasms therapy
- Abstract
Purpose: The results of a randomized, intervention study done in 1993 of psychoeducation for patients with early-stage malignant melanoma showed a beneficial effect on recurrence and survival 6 years after the intervention. In the present study, we replicated the study with 258 Danish patients with malignant melanoma. We also compared recurrence and survival among the participants in the randomized study with 137 patients who refused to participate., Patients and Methods: We randomly assigned 262 patients with primary malignant melanoma to a control or an intervention group. Patients in the intervention group were offered six weekly 2-hour sessions of psychoeducation. Participants and nonparticipants were followed up for vital status and recurrence 4 to 6 years after surgical treatment. Prognostic factors (thickness of the tumor and lymph node status), sex, and age were adjusted for in a Cox regression model (proportional hazards regression) to derive an adjusted survival rate ratio and an adjusted relapse-free survival rate ratio, with 95% CIs., Results: The hazard ratio was 1.30 (95% CI, 0.5 to 3.5) for survival and 0.73 (95% CI, 0.3 to 1.9) for recurrence. Being a nonparticipant increased the risk for death by more than two-fold (hazard ratio, 2.26; 95% CI, 1.0 to 5.2) over that of participants., Conclusion: Psychoeducation did not increase survival or the recurrence-free interval among patients with malignant melanoma; however, nonparticipants had a statistically significantly greater risk for death than participants.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.